Sangamo Therapeutics Inc (SGMO)
0.553
+0.03
(+5.94%)
USD |
NASDAQ |
May 03, 16:00
0.553
0.00 (0.00%)
After-Hours: 20:00
Sangamo Therapeutics Cash from Investing (Quarterly): 37.71M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 37.71M |
| September 30, 2023 | 37.63M |
| June 30, 2023 | 42.47M |
| March 31, 2023 | 35.73M |
| December 31, 2022 | 42.61M |
| September 30, 2022 | -13.46M |
| June 30, 2022 | 28.43M |
| March 31, 2022 | 1.705M |
| December 31, 2021 | 52.64M |
| September 30, 2021 | 60.98M |
| June 30, 2021 | 89.30M |
| March 31, 2021 | 45.29M |
| December 31, 2020 | -130.46M |
| September 30, 2020 | -242.50M |
| June 30, 2020 | 77.61M |
| March 31, 2020 | 23.72M |
| December 31, 2019 | -16.40M |
| September 30, 2019 | -16.22M |
| June 30, 2019 | -12.38M |
| March 31, 2019 | -14.80M |
| December 31, 2018 | 62.84M |
| September 30, 2018 | 82.77M |
| June 30, 2018 | -312.14M |
| March 31, 2018 | -11.57M |
| December 31, 2017 | 27.97M |
| Date | Value |
|---|---|
| September 30, 2017 | -27.06M |
| June 30, 2017 | -84.37M |
| March 31, 2017 | 6.059M |
| December 31, 2016 | 6.266M |
| September 30, 2016 | 32.02M |
| June 30, 2016 | -3.861M |
| March 31, 2016 | -16.30M |
| December 31, 2015 | 45.24M |
| September 30, 2015 | 21.96M |
| June 30, 2015 | -8.19M |
| March 31, 2015 | 18.45M |
| December 31, 2014 | -0.319M |
| September 30, 2014 | -83.48M |
| June 30, 2014 | -20.75M |
| March 31, 2014 | 3.887M |
| December 31, 2013 | -68.95M |
| September 30, 2013 | 1.281M |
| June 30, 2013 | 3.278M |
| March 31, 2013 | -3.731M |
| December 31, 2012 | 7.097M |
| September 30, 2012 | -0.13M |
| June 30, 2012 | -0.397M |
| March 31, 2012 | 4.749M |
| December 31, 2011 | -5.115M |
| September 30, 2011 | 19.64M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-242.50M
Minimum
Sep 2020
89.30M
Maximum
Jun 2021
7.599M
Average
35.73M
Median
Mar 2023
Cash from Investing (Quarterly) Benchmarks
| AIM ImmunoTech Inc | -0.214M |
| Perspective Therapeutics Inc | -0.089M |
| Protalix BioTherapeutics Inc | -0.342M |
| Electromed Inc | -0.087M |
| Armata Pharmaceuticals Inc | -2.39M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -50.54M |
| Cash from Financing (Quarterly) | 0.167M |
| Free Cash Flow | -246.00M |
| Free Cash Flow Per Share (Quarterly) | -0.2995 |
| Free Cash Flow to Equity (Quarterly) | -53.21M |
| Free Cash Flow to Firm (Quarterly) | -53.21M |
| Free Cash Flow Yield | -254.8% |